Lee Y

College of Pharmacy, Chung-Ang University, Seoul, Republic of Korea. yoonjilee@cau.ac.kr.

6 papers · ORCID

ArticlePsilocybin

The therapeutic potential of psilocybin beyond psychedelia through shared mechanisms with ketamine.

Park D, Lee G, Lee WG +3

Europe PMC2025
ArticleKetamine

Can ketamine and other glutamate receptor modulators be considered entactogens?

Hu H, Tillman AN, Fujita M +4

Europe PMC2025
ArticlePsilocybin

A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review.

Pouyan N, Halvaei Khankahdani Z, Younesi Sisi F +14

Europe PMC2022
ArticlePsilocybin

The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.

Rosenblat JD, Husain MI, Lee Y +18

Europe PMC2023
ArticlePsilocybin

Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.

Ling S, Ceban F, Lui LMW +12

Europe PMC2022
ArticlePsilocybin

The emerging role of psilocybin and MDMA in the treatment of mental illness.

Gill H, Gill B, Chen-Li D +11

Europe PMC2020